TEVA — Teva Pharmaceutical Industries Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro Cap

Annual balance sheet for Teva Pharmaceutical Industries, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1,975	2,177	2,165	2,801	3,226
Net Total Accounts Receivable
Net Total Receivables	5,676	4,581	4,529	3,696	3,408
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	13,464	13,005	12,573	12,051	12,486
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,950	6,855	6,477	6,158	6,147
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	57,470	50,640	47,666	44,011	43,480
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,674	13,164	11,027	11,469	12,247
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	43,498	40,614	37,388	36,207	35,973
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	13,972	10,026	10,278	7,804	7,506
Total Liabilities & Shareholders' Equity	57,470	50,640	47,666	44,011	43,479
Total Common Shares Outstanding